PHAR
Income statement / Annual
Last year (2025), Pharming Group N.V.'s total revenue was $377.18 M,
an increase of 22.56% from the previous year.
In 2025, Pharming Group N.V.'s net income was $2.86 M.
See Pharming Group N.V.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$377.18 M |
$307.75 M |
$245.32 M |
$205.62 M |
$225.46 M |
$212.17 M |
$189.39 M |
$154.58 M |
$89.62 M |
$16.69 M |
| Cost of Revenue |
$45.63 M
|
$36.66 M
|
$25.21 M
|
$17.56 M
|
$23.97 M
|
$23.54 M
|
$23.93 M
|
$25.37 M
|
$14.93 M
|
$4.93 M
|
| Gross Profit |
$331.56 M
|
$271.09 M
|
$220.10 M
|
$188.06 M
|
$201.49 M
|
$188.64 M
|
$165.46 M
|
$129.20 M
|
$92.59 M
|
$11.77 M
|
| Gross Profit Ratio |
0.88
|
0.88
|
0.9
|
0.91
|
0.89
|
0.89
|
0.87
|
0.84
|
1.03
|
0.7
|
| Research and Development Expenses |
$98.08 M
|
$86.10 M
|
$68.91 M
|
$52.53 M
|
$79.78 M
|
$38.52 M
|
$31.79 M
|
$33.04 M
|
$22.38 M
|
$16.18 M
|
| General & Administrative Expenses |
$110.78 M
|
$95.35 M
|
$80.68 M
|
$62.44 M
|
$52.58 M
|
$13.40 M
|
$11.16 M
|
$13.98 M
|
$7.17 M
|
$4.88 M
|
| Selling & Marketing Expenses |
$6.66 M
|
$7.39 M
|
$6.82 M
|
$6.41 M
|
$1.98 M
|
$51.60 M
|
$44.72 M
|
$39.51 M
|
$37.70 M
|
$3.19 M
|
| Selling, General & Administrative Expenses |
$117.44 M
|
$102.74 M
|
$87.50 M
|
$68.85 M
|
$54.56 M
|
$65.00 M
|
$55.88 M
|
$53.49 M
|
$44.86 M
|
$8.07 M
|
| Other Expenses |
$94.24 M
|
$91.18 M
|
$69.08 M
|
$48.44 M
|
$51.78 M
|
$8.86 M
|
$9.55 M
|
-$782.43 K
|
-$947.77 K
|
-$352.32 K
|
| Operating Expenses |
$309.75 M
|
$280.02 M
|
$225.49 M
|
$169.83 M
|
$186.12 M
|
$112.38 M
|
$97.22 M
|
$85.74 M
|
$66.30 M
|
$23.91 M
|
| Cost And Expenses |
$355.25 M
|
$316.67 M
|
$250.70 M
|
$187.39 M
|
$210.09 M
|
$135.92 M
|
$121.14 M
|
$111.12 M
|
$67.71 M
|
$28.83 M
|
| Interest Income |
$2.56 M
|
$5.92 M
|
$3.53 M
|
$85.00 K
|
$59.99 K
|
$713.62 K
|
$1.13 M
|
$20.59 K
|
$2.89 K
|
$5.26 K
|
| Interest Expense |
$21.31 M
|
$9.05 M
|
$5.96 M
|
$5.36 M
|
$7.00 M
|
$10.31 M
|
$13.35 M
|
$16.37 M
|
$45.41 M
|
$6.40 M
|
| Depreciation & Amortization |
$10.76 M
|
$16.64 M
|
$15.93 M
|
$13.19 M
|
$22.23 M
|
$8.31 M
|
$5.80 M
|
$3.88 M
|
$3.36 M
|
$795.09 K
|
| EBITDA |
$31.70 M |
$16.89 M |
$9.88 M |
$33.53 M |
$55.30 M |
$58.35 M |
$71.46 M |
$41.88 M |
$25.27 M |
-$13.88 M |
| EBITDA Ratio |
0.08
|
0.05
|
0.04
|
0.16
|
0.25
|
0.28
|
0.38
|
0.27
|
0.28
|
-0.83
|
| Operating Income Ratio |
0.06
|
-0.03
|
-0.02
|
0.09
|
0.07
|
0.36
|
0.36
|
0.28
|
0.24
|
-0.73
|
| Total Other Income/Expenses Net |
-$8.03 M
|
$133.58 K
|
-$6.63 M
|
-$3.25 M
|
$10.79 M
|
-$32.16 M
|
-$15.94 M
|
$0.00
|
-$107.60 M
|
-$6.31 M
|
| Income Before Tax |
$12.88 M
|
-$8.79 M
|
-$12.01 M
|
$14.99 M
|
$26.16 M
|
$44.09 M
|
$52.30 M
|
$885.17 K
|
-$85.69 M
|
-$18.44 M
|
| Income Before Tax Ratio |
0.03
|
-0.03
|
-0.05
|
0.07
|
0.12
|
0.21
|
0.28
|
0.01
|
-0.96
|
-1.1
|
| Income Tax Expense |
$10.34 M
|
$3.47 M
|
-$1.46 M
|
$1.31 M
|
$8.03 M
|
$6.35 M
|
$11.75 M
|
$24.14 M
|
-$11.33 M
|
$0.00
|
| Net Income |
$2.86 M
|
-$12.26 M
|
-$10.55 M
|
$13.67 M
|
$18.13 M
|
$37.75 M
|
$40.56 M
|
$28.59 M
|
-$73.48 M
|
-$18.44 M
|
| Net Income Ratio |
0.01
|
-0.04
|
-0.04
|
0.07
|
0.08
|
0.18
|
0.21
|
0.18
|
-0.82
|
-1.1
|
| EPS |
0.04 |
-0.18 |
-0.14 |
0.17 |
0.23 |
0.47 |
0.52 |
0.35 |
-1.5 |
-0.35 |
| EPS Diluted |
0.04 |
-0.18 |
-0.14 |
0.16 |
0.21 |
0.47 |
0.48 |
0.35 |
-1.5 |
-0.35 |
| Weighted Average Shares Out |
$71.32 M
|
$68.92 M
|
$65.70 M
|
$82.54 M
|
$87.64 M
|
$79.88 M
|
$84.19 M
|
$81.69 M
|
$62.55 M
|
$51.92 M
|
| Weighted Average Shares Out Diluted |
$71.32 M
|
$68.92 M
|
$65.70 M
|
$84.28 M
|
$87.64 M
|
$80.98 M
|
$84.19 M
|
$81.69 M
|
$62.55 M
|
$51.92 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
